vimarsana.com
Home
Live Updates
Lexicon to Present Analyses of INPEFA™ (sotagliflozin) Clinical Study Results and Changing ... : comparemela.com
Lexicon to Present Analyses of INPEFA™ (sotagliflozin) Clinical Study Results and Changing ...
THE WOODLANDS, Texas, Aug. 21, 2023 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that analyses of clinical study results relating to INPEFA™ (sotagliflozin), its recently approved drug
Related Keywords
Michigan ,
United States ,
Texas ,
Amsterdam ,
Noord Holland ,
Netherlands ,
Ann Arbor ,
Bertram Pitt ,
Carrie Siragusa ,
Marc Bonaca ,
Alina Cocuzza ,
Drug Administration ,
Lexicon Pharmaceuticals Inc ,
Lexicon Pharmaceuticals ,
Exchange Commission ,
Nasdaq ,
Amsterdam Convention Center ,
University Of Michigan ,
University Of Colorado Anschutz Medical Campus ,
School Of Medicine ,
Convention Center ,
Science Box ,
Colorado Anschutz Medical Campus ,
New England Journal ,
Recent Worsening Heart Failure ,
Investor Inquiries ,
Media Inquiries ,
,
comparemela.com © 2020. All Rights Reserved.